default author photo

Yifei Cheng

Peking University - Institute of Hematology

Beijing

China

  • Peking University - Institute of Hematology

SCHOLARLY PAPERS

2

DOWNLOADS

175

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome

Downloads 120 (596,393)
Citation 1

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome

Number of pages: 29 Posted: 01 Oct 2021
Huidong Guo, Ming Wang, Bixia Wang, Liping Guo, Yifei Cheng, Zhidong Wang, Yu-Qian Sun, Yu Wang, Ying-Jun Chang and Xiao-Jun Huang
Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Institute of Hematology, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Institute of Hematology, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation and Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation
Downloads 88 (761,092)
Citation 1

Abstract:

Loading...

PRDM1, multiomics, T cell hyporesponsiveness, HSCT, GVHD

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome

Number of pages: 47 Posted: 19 Nov 2021
Huidong Guo, Ming Wang, Bixia Wang, Liping Guo, Yifei Cheng, Zhidong Wang, Yu-Qian Sun, Yu Wang, Ying-Jun Chang and Xiao-Jun Huang
Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Institute of Hematology, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Institute of Hematology, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation and Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation
Downloads 32 (1,326,242)

Abstract:

Loading...

PRDM1, multiomics, T cell hyporesponsiveness, HSCT, GVHD

2.

Optimized Therapeutic Strategy for Patients with Refractory or Relapsed Acute Myeloid Leukemia: Long-Term Clinical Outcome and Health-Relate Quality of Life Assessment

Number of pages: 34 Posted: 17 Jan 2022
Chen-Hua Yan, Yu Wang, Yu-qian Sun, Yifei Cheng, Xiao-dong Mo, Feng-rong Wang, Yu-hong Chen, Yuan-yuan Zhang, Ting-ting Han, Huan Chen, Lan-Ping Xu, Xiao-Hui Zhang, Kai-yan Liu and Xiao-Jun Huang
Peking University - Institute of Hematology, Peking University - Institute of Hematology, affiliation not provided to SSRN, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology, Peking University - Institute of Hematology and Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation
Downloads 55 (1,010,164)

Abstract:

Loading...

refractory, relapsed, acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation, optimized